• Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China;
Wei Wenbin, Email: weiwenbintr@163.com
Export PDF Favorites Scan Get Citation

Ciliary body tumor is a rare intraocular tumor. Due to its unique anatomical location, its correct diagnosis and reasonable treatment are very difficult problems. In terms of diagnosis and differential diagnosis, ophthalmologists need to fully utilize the role of slit lamp microscope and transillumination experiment to capture secondary changes in the anterior segment caused by hidden ciliary body tumors, such as monocular localized cataract, lens indentation, and pigment dissemination, etc. Ophthalmological imaging methods, especially ultrasound biomicroscopy, can achieve the purpose of early detection and early diagnosis. According to the size, location and morphological characteristics of the tumor, a reasonable treatment plan is formulated. Since ciliary body tumors are mostly benign, the recurrence rate of local resection is low, which can satisfy the pathological diagnosis and preserve part of the patient's vision. Therefore, eye-preserving treatment should be advocated. However, enucleation remains the treatment of choice for tumors that are too large to be treated with local excision or radiation, eyes with refractory glaucoma, and tumors that do not respond to radiation therapy.

Citation: Wei Wenbin, Wang Qian. Pay attention to the correct diagnosis and rational treatment of ciliary body tumors. Chinese Journal of Ocular Fundus Diseases, 2022, 38(3): 178-181. doi: 10.3760/cma.j.cn511434-20220221-00099 Copy

  • Previous Article

    Pay attention to the research on the mechanism of retinoblastoma and the methods of diagnosis and treatment
  • Next Article

    Cause of death of children with intraocular retinoblastoma in the Beijing Children's Hospital 2009-2017